Santa Cruz Biotechnology offers a broad range of KCNC3 monoclonal antibodies for research focused on understanding KCNC3 protein function. KCNC3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KCNC3, also known as K+ channel, voltage gated, Shaw-related subfamily, member 3, plays a critical role in neuronal excitability and signal transmission. KCNC3 regulates action potentials and maintains proper neuronal function. Mutations in KCNC3 can lead to various neurological disorders, highlighting its significance in neuroscience research. KCNC3 expression patterns vary across different regions of the nervous system, making it an important focus for understanding neural circuit function. Research has shown that KCNC3 channels contribute to the rapid repolarization of action potentials in neurons. KCNC3 activity influences neurotransmitter release and synaptic plasticity. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance neuroscience discoveries and contribute to understanding neurological disease mechanisms.